↓ Skip to main content

Dove Medical Press

Efficacy and Prognosis of First-Line EGFR-Tyrosine Kinase Inhibitor Treatment in Older Adults Including Poor Performance Status Patients with EGFR-Mutated Non-Small-Cell Lung Cancer

Overview of attention for article published in Cancer Management and Research, September 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (56th percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
11 Mendeley
Title
Efficacy and Prognosis of First-Line EGFR-Tyrosine Kinase Inhibitor Treatment in Older Adults Including Poor Performance Status Patients with EGFR-Mutated Non-Small-Cell Lung Cancer
Published in
Cancer Management and Research, September 2021
DOI 10.2147/cmar.s322967
Pubmed ID
Authors

Cheng-Yu Chang, Chung-Yu Chen, Shih-Chieh Chang, Yi-Chun Lai, Yu-Feng Wei

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 11 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 2 18%
Lecturer 2 18%
Unspecified 1 9%
Other 1 9%
Student > Ph. D. Student 1 9%
Other 1 9%
Unknown 3 27%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 2 18%
Medicine and Dentistry 2 18%
Biochemistry, Genetics and Molecular Biology 2 18%
Unspecified 1 9%
Nursing and Health Professions 1 9%
Other 1 9%
Unknown 2 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 September 2021.
All research outputs
#13,511,215
of 23,310,485 outputs
Outputs from Cancer Management and Research
#465
of 2,022 outputs
Outputs of similar age
#183,520
of 429,594 outputs
Outputs of similar age from Cancer Management and Research
#18
of 121 outputs
Altmetric has tracked 23,310,485 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,022 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 429,594 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.
We're also able to compare this research output to 121 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.